Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

Presentation TVT 2023

Direct Oral Anticoagulants Versus Vitamin K Antagonists in Atrial Fibrillation Patients With Bioprosthetic Valves: A Systematic Review, Meta-Analysis and Network Meta-Analysis

Presenter: Mustafa Suppah

June 08, 2023

Presentation TVT 2023

Patients With AS and Atrial Fibrillation: Updates on the WATCH-TAVR Trial

Presenter: Brian Whisenant

June 08, 2023

Presentation TVT 2023

Comparative Effectiveness of Left Atrial Appendage Closure and Direct Oral Anticoagulants in Atrial Fibrillation Patients: A Meta-Analysis

Presenter: Olayiwola Bolaji

June 08, 2023

Presentation TVT 2023

Colchicine for Prevention of Post PFO Closure Atrial Fibrillation

Presenter: Veronica Andre

June 08, 2023

Presentation TVT 2022

LAAO for Atrial Fibrillation After TAVR: The Other Elephant In The Room

Presenter: Amar Krishnaswamy

June 10, 2022

Presentation TVT 2021

Percutaneous Left Atrial Appendage Closure Versus Oral Anticoagulation for Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Presenter: Yousif Ahmad

July 22, 2021

Presentation TVT 2021

PFO Closure and Atrial Fibrillation

Presenter: Robert Sommer

July 22, 2021

Presentation TVT 2019

Impact of Pre-Existing Atrial Fibrillation on Clinical Outcomes in Patients Who Underwent Balloon-Expandable Transcatheter Aortic Valve Replacement

Presenter: Hyungdon Kook

June 14, 2019

Presentation TVT 2019

Operator and Institutional Requirements for LAA Occlusion for Non-Valvular Atrial Fibrillation

Presenter: Hemal Gada

June 14, 2019

Presentation TVT 2019

Critical Appraisal of the Advantages and Limitations of Warfarin, NOACs, and Ablation in Patients With Non-Valvular Atrial Fibrillation

Presenter: DJ Lakkireddy

June 13, 2019

Presentation TVT 2017

Managing AS Patients With Atrial Fibrillation After TAVR Pharmacotherapy Considerations and LAAC Possibilities

Presenter: Samir R. Kapadia

June 16, 2017

Presentation TVT 2016

Combined TAVR and Left Atrial Appendage Closure in AS Patients With Atrial Fibrillation: Case Selection, Procedural Consideration, and Clinical Outcomes

Presenter: Fabian Nietlispach

June 17, 2016

Presentation TVT 2016

Complexities of Managing AS Patients With Atrial Fibrillation After TAVR

Presenter: Samir R. Kapadia

June 17, 2016

Presentation TVT 2016

Incidence and Clinical Impact of Atrial Fibrillation in TAVR Patients

Presenter: Philippe Généreux

June 16, 2016

Presentation TVT 2013

Predictors of TAVR: Associated Strokes: New Onset Atrial Fibrillation, Postdilatation, and Others

Presenter: Josep Rodes-Cabau

June 12, 2013

Presentation TVT 2012

The Evolving Standard of Care: Oral Antithrombotic Agents for Stroke Prevention in Atrial Fibrillation

Presenter: Gregg Stone

June 05, 2012

Presentation TVT 2012

The Evolving Standard of Care: Atrial Fibrillation Ablation

Presenter: Shephal Doshi

June 05, 2012

Advertisement

Direct Oral Anticoagulants Versus Vitamin K Antagonists in Atrial Fibrillation Patients With Bioprosthetic Valves: A Systematic Review, Meta-Analysis and Network Meta-Analysis

Patients With AS and Atrial Fibrillation: Updates on the WATCH-TAVR Trial

Comparative Effectiveness of Left Atrial Appendage Closure and Direct Oral Anticoagulants in Atrial Fibrillation Patients: A Meta-Analysis

Colchicine for Prevention of Post PFO Closure Atrial Fibrillation

LAAO for Atrial Fibrillation After TAVR: The Other Elephant In The Room

Percutaneous Left Atrial Appendage Closure Versus Oral Anticoagulation for Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

PFO Closure and Atrial Fibrillation

Impact of Pre-Existing Atrial Fibrillation on Clinical Outcomes in Patients Who Underwent Balloon-Expandable Transcatheter Aortic Valve Replacement

Operator and Institutional Requirements for LAA Occlusion for Non-Valvular Atrial Fibrillation

Critical Appraisal of the Advantages and Limitations of Warfarin, NOACs, and Ablation in Patients With Non-Valvular Atrial Fibrillation

Managing AS Patients With Atrial Fibrillation After TAVR Pharmacotherapy Considerations and LAAC Possibilities

Combined TAVR and Left Atrial Appendage Closure in AS Patients With Atrial Fibrillation: Case Selection, Procedural Consideration, and Clinical Outcomes

Complexities of Managing AS Patients With Atrial Fibrillation After TAVR

Incidence and Clinical Impact of Atrial Fibrillation in TAVR Patients

Predictors of TAVR: Associated Strokes: New Onset Atrial Fibrillation, Postdilatation, and Others

The Evolving Standard of Care: Oral Antithrombotic Agents for Stroke Prevention in Atrial Fibrillation

The Evolving Standard of Care: Atrial Fibrillation Ablation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content